These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24348012)

  • 1. Diabetic papillopathy with macular edema treated with intravitreal ranibizumab.
    Kim M; Lee JH; Lee SJ
    Clin Ophthalmol; 2013; 7():2257-60. PubMed ID: 24348012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic papillopathy treated with intravitreal ranibizumab.
    Yildirim M; Kilic D; Dursun ME; Dursun B
    Int Med Case Rep J; 2017; 10():99-103. PubMed ID: 28356776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic papillopathy with macular edema treated with intravitreal bevacizumab.
    Al-Hinai AS; Al-Abri MS; Al-Hajri RH
    Oman J Ophthalmol; 2011 Sep; 4(3):135-8. PubMed ID: 22279402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal triamcinolone acetonide for acute radiation papillopathy.
    Shields CL; Demirci H; Marr BP; Mashayekhi A; Dai VV; Materin MA; Shields JA
    Retina; 2006; 26(5):537-44. PubMed ID: 16770260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic papillopathy: two case reports in individuals with adult onset diabetes mellitus.
    Keely KA; Yip B
    J Am Optom Assoc; 1997 Sep; 68(9):595-603. PubMed ID: 9308304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swept-source optical coherence tomography angiography findings of diabetic papillopathy after intravitreal bevacizumab.
    Cho IH; Ma DJ
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100748. PubMed ID: 32490284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema.
    Battaglia Parodi M; Iacono P; Cascavilla ML; Zucchiatti I; Kontadakis DS; Vergallo S; Bandello F
    Eur J Ophthalmol; 2010; 20(6):1076-8. PubMed ID: 20954148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone.
    Karacorlu M; Ozdemir H; Karacorlu S; Alacali N
    Int Ophthalmol; 2004 Mar; 25(2):113-6. PubMed ID: 15290890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion.
    Risard SM; Pieramici DJ; Rabena MD; Basefsky JC; Avery RL; Castellarin AA; Nasir MA; See RF; Couvillion SS
    Retina; 2011 Jun; 31(6):1060-7. PubMed ID: 21283055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swept-source optical coherence tomography angiography of diabetic papillopathy: a case report.
    Choi JM; Lee HJ; Ma DJ
    BMC Ophthalmol; 2020 May; 20(1):194. PubMed ID: 32414351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
    Mukkamala L; Bhagat N; Zarbin MA
    Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study).
    Ehrlich R; Pokroy R; Segal O; Goldstein M; Pollack A; Hanhart J; Barak Y; Kehat R; Shulman S; Vidne O; Abu Ahmad W; Chowers I
    Eur J Ophthalmol; 2019 Mar; 29(2):229-233. PubMed ID: 29916263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.
    Nowacka B; Kirkiewicz M; Mozolewska-Piotrowska K; Lubiński W
    Doc Ophthalmol; 2016 Apr; 132(2):111-22. PubMed ID: 27000269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.
    Al-Haddad CE; Jurdi FA; Bashshur ZF
    Am J Ophthalmol; 2004 Jun; 137(6):1151-3. PubMed ID: 15183815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy.
    Chae JB; Joe SG; Yang SJ; Lee JY; Sung KR; Kim JY; Kim JG; Yoon YH
    Retina; 2014 Jan; 34(1):149-56. PubMed ID: 23807186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation.
    Yan P; Qian C; Wang W; Dong Y; Wan G; Chen Y
    Ther Clin Risk Manag; 2016; 12():527-33. PubMed ID: 27103811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with intravitreal aflibercept and subtenon corticosteroids in eyes with severe diabetic papillopathy: two case reports.
    Arapi I; Neri P; Giovannini A; Grezda A
    J Med Case Rep; 2021 Oct; 15(1):518. PubMed ID: 34674724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.